PEOPLE - Boston Life Sciences (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Boston Life Sciences (Boston, Massachusetts), whose products in development include Altropane and Fluoratec radioimaging agents for the diagnosis of Parkinson's Disease and Attention Deficit Hyperactivity disorder, has appointed Robert Rosenthal as president and COO. Dr Rosenthal most recently served as president and CEO of analytical instrument company Thermo Optek.